BioStem Technologies (BSEM) vs Genenta Science S.p.A. (GNTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BioStem Technologies (BSEM) has outperformed Genenta Science S.p.A. (GNTA) over the past year, losing 50.5% versus a loss of 76.1%. BioStem Technologies is the larger company by market cap ($45.7 million vs $36.3 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSEM | GNTA |
|---|---|---|
| Share price | $2.45 | $0.7525 |
| Market cap | $45.75M | $36.28M |
| 1-day change | +2.55% | -0.33% |
| YTD return | -37.27% | -49.33% |
| 1-year return | -50.52% | -76.11% |
| 5-year return | +70.71% | — |
| P/E ratio (TTM) | 2.78 | — |
| Forward P/E | 8.45 | — |
| EPS (TTM) | $0.88 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.40 | $10.00 |
| 52-week low | $2.25 | $0.55 |
| Distance from 52-week high | -70.83% | -92.48% |
| Average volume | 120.39K | 61.48K |
| Shares outstanding | 18.67M | 48.22M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BSEM has outperformed GNTA by 25.6 percentage points over the past year.
BSEM vs GNTA FAQ
Which is bigger, BioStem Technologies or Genenta Science S.p.A.?
BioStem Technologies (BSEM) is larger, with a market capitalization of $45.75M compared with $36.28M for Genenta Science S.p.A. (GNTA).
Which stock has performed better over the past year, BSEM or GNTA?
BSEM returned -50.52% over the past 12 months, compared with -76.11% for GNTA (price return, excluding dividends). Past performance does not predict future results.
Are BioStem Technologies and Genenta Science S.p.A. in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.